Blue Light and Your Skin: What the Evidence Shows

A phone screen is not a tanning bed. That distinction has got lost somewhere between a genuine area of dermatological research and a retail category built to sell a second serum for daytime.

Blue light, also called high-energy visible (HEV) light, sits at the 400–490 nanometre end of the visible spectrum, just next to ultraviolet. It is emitted by the sun in far greater quantities than by any screen, and also by phones, laptops, and LED lighting in much smaller amounts. Over the past several years, a wave of “blue light protection” serums and mists has suggested that a working day in front of a laptop is now a meaningful skin threat. The claim deserves a direct answer: what has the research actually shown, and what should a protocol account for.

What the Research Has Actually Shown

Visible light’s effect on skin is a genuine field of study, and it is older than the current trend. A 2010 study by Mahmoud and colleagues, published in the Journal of Investigative Dermatology, found that visible light exposure could induce persistent pigmentation in melanin-competent skin, with the effect most pronounced in darker Fitzpatrick skin types. A 2014 study by Duteil and colleagues in Pigment Cell & Melanoma Research reached a similar conclusion, showing that visible light produced pigmentation through a different mechanism to UVB exposure. Separately, a 2017 study by Nakashima, Ohta and Wolf in Free Radical Biology and Medicine found that blue light at 415 nanometres could generate reactive oxygen species and oxidative stress in live skin tissue under laboratory conditions.

These are real findings, and they are the reason blue light is discussed in dermatology at all. What they are not is evidence about a laptop. Each of these studies used direct, sustained exposure from concentrated light sources, at intensities and durations that do not resemble a person glancing at a screen from thirty centimetres away for part of a working day. No published clinical trial has demonstrated that ordinary device use, at ordinary viewing distances, reproduces the pigmentation or oxidative effects seen under laboratory exposure.

Why Sunlight Is the Comparison That Matters

The sun emits visible light, including the blue end of the spectrum, at an intensity many times greater than any screen. A person who is outdoors in Queensland for part of the day is receiving substantially more HEV light from ambient daylight than from a phone held at reading distance. This is not an argument for ignoring device exposure. It is the reason a device-specific product category is, at minimum, addressing the smaller part of the equation while implying it is the larger one.

Skin function doesn’t distinguish the source of a photon by its marketing category. A defence built for ambient light, including its visible component, already covers the exposure a screen contributes.

What the Protocol Already Accounts For

This is where the trend and the clinical answer diverge. Aliangé does not formulate a dedicated device-light product, because the two mechanisms with genuine evidence behind them, oxidative stress and visible-light pigmentation, are already addressed within the existing AM Protocol.

Step 1: Cleanse. Daily Devotion Cleanser removes the surface residue that can otherwise contribute to oxidative load without disrupting barrier function.

Step 2: Antioxidant Defence. Jellyfish Peptide x Antioxidant Serum is formulated to help neutralise oxidative stress at the skin surface, the same pathway implicated in the laboratory blue-light studies above. This is not a response manufactured for the blue-light conversation. It is the standing antioxidant step of the AM Protocol, doing the job it was already designed to do.

Step 3: Broad-Spectrum Protection. Day Cream SPF 15 is indicated for daily use as part of the AM Protocol, supporting the skin against the broader visible and ultraviolet light environment, not a single wavelength band in isolation.

A protocol addresses mechanisms. A trend addresses a headline. The two are not the same exercise, and skin function is only ever served by the first.

Common Questions

Does my phone age my skin faster than the sun?
No clinical evidence supports this. The sun delivers substantially more visible and ultraviolet light than a device screen at normal viewing distance. The laboratory studies showing blue-light effects on skin used direct, concentrated exposure well beyond ordinary screen use.

Do I need a separate blue light serum?
Not within the Aliangé system. The AM Protocol’s antioxidant serum and SPF step are formulated to support the skin against oxidative stress and broad-spectrum light exposure, which is the same mechanism a device-specific product is targeting.

Should I still be careful with screen time and my skin?
Screen habits matter more for posture, eye strain, and sleep than for skin function directly. If a specific pigmentation or sensitivity concern exists, that is a conversation for individual assessment, not a product category.

The Protocol, Not the Panic

Aliangé is built on protocols because skin outcomes come from consistent, evidence-based systems, not from reacting to each new ingredient conversation. The AM Protocol already accounts for the mechanisms blue light exposure can plausibly affect, through the Jellyfish Peptide x Antioxidant Serum and Day Cream SPF 15 steps. For a full morning-to-night system, see The Protocol.

Dr Alison Jamieson — MBBS, FRACGP, Dip Derm